Global Market Study on Diabetic Nephropathy Asia to Witness Highest Growth by 2020

By -


A latest market research report added to the repository of Market Research Reports Search Engine (MRRSE) states that the diabetic nephropathy market will report a moderate CAGR at 5.6% from 2014 through 2020.

 The report, published by Persistence Market Research, is titled ‘Global Market Study on Diabetic Nephropathy Market – Asia to Witness Highest Growth by 2020’. The study says that the diabetic nephropathy market approximated US$2,262.2 million in 2014, and will be worth US$ 3,145.9 million by the end of 2020.

Diabetic nephropathy, a condition that increase the risk of mortality in diabetes patients, is being widely reported across the world due to the sheer increase in the number of obese people and diabetics. The disease affects the kidneys, ultimately rendering them ineffective. This has necessitated investments in formulating treatments for diabetic nephropathy, leading to a teeming therapy pipeline in major markets of the world.


The drugs, however, are faced with long approval times (essentially because there are scores of regulatory hurdles) making it difficult for pharma companies to bring novel products to the market in short turnaround times. Moreover, there is a general lack of broader therapeutic management for the disease. All of these factors will play a role in curtailing the growth of the global diabetic nephropathy market.

The report notes that North America has the highest degree of awareness about diabetic nephropathy. Government initiatives such as the National Kidney Disease Education Program can be credited for this. The market here continues to organically grow because of a parallel increase in the number of people suffering from diabetes in America. Estimates from the SciELO Public Health state that in 2000 about 35 million people in North America suffered from diabetes mellitus; by 2025, this number will soar to 64 million in the region. 
The
European diabetic nephropathy market is also on an upswing because here too, diabetes is increasingly being reported. International Diabetes Federation (IDF) says that the amount expended on diabetes treatment in the European region was pegged at US$105.5 billion in 2010, and will hit US$124.6 billion by 2030.

 The highest potential for growth lies in the Asia Pacific diabetic nephropathy market. The region is witnessing an escalation in the incidence of diabetic nephropathy in Japan and other Southeast Asian nations.

Moving forward, companies in the diabetic nephropathy market have a lucrative opportunity in developing combination therapies.


Table of Content


Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Assumptions
Chapter 2 Market Synopsis

 Chapter 3 Porter’s Five Forces Analysis
3.1 Bargaining Power of Suppliers
3.2 Bargaining Power of Buyers
3.3 Threat of New Entrants
3.4 Threat of Substitutes
3.5 Intensity of Rivalry

Chapter 4 Industry Overview
4.1 Market Definition
4.2 Market Drivers
     4.2.1 Increasing prevalence of diabetes
     4.2.2 Globally rising obesity increasing the prevalence of diabetes
     4.2.3 Increasing R&D investments in drug discovery and development
     4.2.4 Rising awareness among people about diabetes and kidney-related disorders
4.3 Impact Analysis of Market Drivers
4.4 Market Restraints
     4.4.1 Strict regulatory requirements and long approval time for drugs
     4.4.2 Lack of comprehensive therapeutic management for diabetic nephropathy
4.5 Impact Analysis of Market Restraints
4.6 Market Trends
     4.6.1 Increasing usage of combination therapy is gaining popularity in diabetic nephropathy market

 Chapter 5 Global Market Size and Forecast

 Chapter 6 Market Size and Forecast by Mode of Treatment
6.1 Disease Modifying Therapies
     6.1.1 Angiotensin-Converting Enzyme Inhibitors
     6.1.2 Angiotensin Receptor Blockers
     6.1.3 Diuretics
     6.1.4 Calcium Channel Blockers
     6.1.5 Renin Inhibitors
     6.1.6 Connective Tissue Growth Factor Inhibitors
     6.1.7 Antioxidant Inflammation Modulator
     6.1.8 Monocyte Chemoattractant Proteins Inhibitor
     6.1.9 Endothelin-A Receptor Antagonist
     6.1.10 G Protein-Coupled Receptors

 Chapter 7 Market Size and Forecast by Geography
7.1 North America
     7.1.1 Scenario in the U.S.
     7.1.2 Scenario in Canada
7.2 Europe
     7.2.1 Scenario in Germany
     7.2.2 Scenario in France
     7.2.3 Scenario in the U.K.
7.3 Asia
     7.3.1 Scenario in Japan
     7.3.2 Scenario in China
     7.3.3 Scenario in India
 Chapter 8 Pipeline Drugs for Diabetic Nephropathy
8.1 Drugs Under Development for Diabetic Nephropathy
Chapter 9 Competitive Scenario
9.1 Competitive Benchmarking
 Chapter 10 Company Profiles
10.1 Novartis AG
     10.1.1 Company overview
     10.1.2 Products and services
     10.1.3 Financial performance
     10.1.4 Key developments
10.2 Merck & Co., Inc.
     10.2.1 Company overview
     10.2.2 Products and services
     10.2.3 Financial performance
     10.2.4 Key developments
10.3 Pfizer, Inc.
     10.3.1 Company overview
     10.3.2 Products and services
     10.3.3 Financial performance
     10.3.4 Key developments
10.4 Abbott Laboratories
     10.4.1 Company overview
     10.4.2 Products and services
     10.4.3 Financial performance
     10.4.4 Key developments
10.5 Sanofi
     10.5.1 Company overview
     10.5.2 Products and services
     10.5.3 Financial performance
     10.5.4 Key developments
10.6 Eli Lilly and Company
     10.6.1 Company overview
     10.6.2 Products and segments
     10.6.3 Financial performance
     10.6.4 Key developments
10.7 Reata Pharmaceuticals, Inc.
     10.7.1 Company overview
     10.7.2 Products and segments
     10.7.3 Financial performance
     10.7.4 Key developments
10.8 Bayer AG
     10.8.1 Company overview
     10.8.2 Products and segments
     10.8.3 Financial performance
     10.8.4 Key developments
10.9 AbbVie, Inc.
     10.9.1 Company overview
     10.9.2 Products and segments
     10.9.3 Financial performance
     10.9.4 Key developments
10.10 Mitsubishi Tanabe Pharma Corporation
     10.10.1 Company overview
     10.10.2 Products and segments
     10.10.3 Financial performance
     10.10.4 Key developments


About Us:
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. Headquartered in New York, U.S., MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact
State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-618-1030
Website: http://www.mrrse.com/

Comments

Post a Comment

Popular posts from this blog

New reports Acetone Market Global Industry Analysis and Opportunity Assessment, 2014 – 2020

By -
Image
Research Reports Search Engine (MRRSE) announces the addition of a new report titled ‘ Acetone Market: Global Industry Analysis and Opportunity Assessment, 2014–2020’ to its database. The report finds that global acetone consumption stood at 5.9 million tonnes in 2014, and is poised to grow at a meager 3% CAGR from 2014 to 2020 to reach a little over 7.21 million tonnes by 2020. The report has been published by Future Market Insights (FMI). Global Acetone Market Analysis Forecast: The key drivers identified by the study are: The chemical sector’s dependence on acetone as a solvent, the use of acetone as a chemical in several processes, and the escalating use of BPA in the global automobile sector. On the other hand, the report warns that hurdles such as increasingly stringent government mandates for the chemical industry and the growing acceptance of bio-based acetone will restrict growth to some degree. In order to offer highly detailed insights into various face
Read more

Global Industrial Logistics Robots Market Shares, Status, Opportunities, Market Forecasts, 2014 to 2020

By -
The main benefits of incorporating industrial logistics robots are doing tasks that people cannot or will not perform, minimizing cost of labor, reducing the frequency as well as severity of injuries to workers, enabling processes that are speedier, more efficient, and organized, minimizing product damage, avoiding duplication, and mitigating loss arising from theft. To Get Browse Full Report with TOC: http://www.mrrse.com/reports/industrial-logistics-robots-market Developing industrial logistics robots is a rather tedious process that requires high capital and this often results in the postponement of investment. Achieving this feat is the biggest challenge at the moment. Logistics robots need to be customized according to the needs of a specific industry and this renders the process even more expensive. Another challenge that arises from the technological shift is the task of training new and existing staff to be able to handle and use these new systems. Logistic rob
Read more

Digital Transformation in Healthcare Spurred by Growing Popularity of mHealth Services

By -
Image
Digital transformation has had a revolutionary impact on almost every sphere of operation: manufacturing, retail, public sector, and banking, financial services, and insurance. However, when it comes to the healthcare industry, digital transformation is termed as a game changer. Widespread Usage of Digital Transformation in Healthcare Digital health has crept into every discipline of medicine, healthcare, and pharmaceuticals. Digital health platforms are being used across hospitals, clinics, and nursing homes in the form of mobile health apps, wireless solutions, and telehealth. These platforms are being implemented not only for remote monitoring of chronic diseases among patients, but also to access electronic personal health and medical records via mobiles and broadband services. The thriving mHealth market is a classic example of digital transformation in the healthcare sector. Browse the full Global Digital Transformation Market Report:  http://www.mrrse.com/dig
Read more